TransEnterix (TRXC) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

TransEnterix (NYSEAMERICAN:TRXC) announced its earnings results on Thursday. The medical instruments supplier reported ($0.06) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.01, Briefing.com reports. The business had revenue of $5.40 million for the quarter, compared to the consensus estimate of $5.40 million. The firm’s revenue was up 2850.8% compared to the same quarter last year.

Shares of TRXC opened at $3.22 on Friday. TransEnterix has a 12 month low of $1.27 and a 12 month high of $6.98.

Several research analysts have recently commented on TRXC shares. Zacks Investment Research cut shares of TransEnterix from a “hold” rating to a “sell” rating in a report on Wednesday, July 25th. LADENBURG THALM/SH SH raised shares of TransEnterix from a “neutral” rating to a “buy” rating and set a $5.00 target price on the stock in a report on Friday. Finally, BTIG Research reaffirmed a “hold” rating on shares of TransEnterix in a report on Tuesday, September 25th.

In related news, CFO Joseph P. Slattery sold 64,651 shares of the stock in a transaction that occurred on Tuesday, October 2nd. The shares were sold at an average price of $5.74, for a total transaction of $371,096.74. Following the sale, the chief financial officer now owns 11,951 shares in the company, valued at approximately $68,598.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Joseph P. Slattery sold 4,924 shares of the stock in a transaction that occurred on Tuesday, September 25th. The stock was sold at an average price of $7.03, for a total transaction of $34,615.72. Following the sale, the chief financial officer now owns 4,924 shares in the company, valued at approximately $34,615.72. The disclosure for this sale can be found here. Insiders have sold 2,909,224 shares of company stock worth $18,271,761 over the last ninety days.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. boosted its position in TransEnterix by 467.9% in the second quarter. BlackRock Inc. now owns 9,870,565 shares of the medical instruments supplier’s stock valued at $43,036,000 after buying an additional 8,132,481 shares in the last quarter. Global X Management Co LLC acquired a new stake in TransEnterix in the second quarter valued at approximately $11,212,000. Millennium Management LLC boosted its position in TransEnterix by 787.5% in the first quarter. Millennium Management LLC now owns 1,895,115 shares of the medical instruments supplier’s stock valued at $3,222,000 after buying an additional 1,681,583 shares in the last quarter. UBS Group AG boosted its position in TransEnterix by 1,658.3% in the first quarter. UBS Group AG now owns 906,280 shares of the medical instruments supplier’s stock valued at $1,541,000 after buying an additional 854,737 shares in the last quarter. Finally, Eagle Asset Management Inc. boosted its position in TransEnterix by 152.9% in the second quarter. Eagle Asset Management Inc. now owns 791,165 shares of the medical instruments supplier’s stock valued at $3,449,000 after buying an additional 478,286 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/10/transenterix-trxc-posts-quarterly-earnings-results-beats-estimates-by-0-01-eps.html.

About TransEnterix

TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.

Recommended Story: How are the companies in the S&P 500 selected?

Earnings History for TransEnterix (NYSEAMERICAN:TRXC)

Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply